Topiramate
Product Images NDC 70934-606

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70934-606). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 606 30 Master Bottle Label Approval Rev A 03 20)

NDC 70934-606-30 is a prescription drug identified as Topiramate, available in the form of 50 mg Tablets, USP with 30 tablets in each bottle. The drug is only available upon a prescription. The rest of the text contains errors and is not readable.*

FDA Label Image

Structured Product Formula For Topiramate (Dc0a034e Df8a 4de6 Be65 82ebf72ddb48 01)

FDA Label Image

Structured Product Formula For Topiramate (Dc0a034e Df8a 4de6 Be65 82ebf72ddb48 02)

The text shows a comparison between two doses of topiramate (50mg/day and 400mg/day) in relation to the cumulative rates for time to the first seizure, as represented in a graph. The statistical significance of the difference between these two doses is also given (P = 0.0002). The graph shows time in days on the x-axis and the cumulative rate on the y-axis.*

FDA Label Image

Topiramate Tablets Usp (Dc0a034e Df8a 4de6 Be65 82ebf72ddb48 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.